MedTrace Logo

BRILMA Block in Breast-Conserving Surgery

NCT07056413 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-07-09

No results posted yet for this study

Summary

Regional analgesia technique in addition to multimodal analgesia in breast-conserving surgery aims to reduce opioid consumption. This study evaluates the postoperative analgesic efficacy of ultrasound-guided BRILMA block in patients undergoing breast conserving surgery.

Conditions

  • Postoperative Pain

Interventions

PROCEDURE

BRILMA block

20 ml 0.25 % bupivacaine was injected into the fascial plane between the serratus anterior muscle and the external intercostal muscle at T4 level.

OTHER

Standard intravenous analgesia.

Standard intravenous analgesia.

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Nükhet Sivrikoz, Assoc. Prof. Dr. · Attending anesthesiologist

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-22
Primary Completion
2025-05-05
Completion
2025-05-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07056413 on ClinicalTrials.gov